Geneos Wealth Management’s Baker Hughes BKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.31M | Buy |
119,724
+12,968
| +12% | +$750K | 0.17% | 145 |
|
|
2025
Q4 | $4.86M | Sell |
106,756
-2,947
| -3% | -$140K | 0.12% | 207 |
|
|
2025
Q3 | $5.34M | Buy |
109,703
+3,191
| +3% | +$141K | 0.14% | 192 |
|
|
2025
Q2 | $4.08M | Sell |
106,512
-98,959
| -48% | -$3.73M | 0.1% | 254 |
|
|
2025
Q1 | $9.03M | Buy |
205,471
+85,191
| +71% | +$3.8M | 0.13% | 189 |
|
|
2024
Q4 | $4.93M | Buy |
120,280
+4,125
| +4% | +$166K | 0.17% | 136 |
|
|
2024
Q3 | $4.2M | Buy |
116,155
+115,795
| +32,165% | +$4.07M | 0.16% | 150 |
|
|
2024
Q2 | $12.7K | Sell |
360
-54
| -13% | -$1.77K | ﹤0.01% | 1485 |
|
|
2024
Q1 | $13.9K | Hold |
414
| – | – | ﹤0.01% | 1463 |
|
|
2023
Q4 | $14.2K | Buy |
414
+13
| +3% | +$443 | ﹤0.01% | 1458 |
|
|
2023
Q3 | $14.2K | Hold |
401
| – | – | ﹤0.01% | 1475 |
|
|
2023
Q2 | $12.7K | Hold |
401
| – | – | ﹤0.01% | 1510 |
|
|
2023
Q1 | $11.6K | Hold |
401
| – | – | ﹤0.01% | 1510 |
|
|
2022
Q4 | $11.8K | Hold |
401
| – | – | ﹤0.01% | 1484 |
|
|
2022
Q3 | $8K | Sell |
401
-32
| -7% | -$801 | ﹤0.01% | 1561 |
|
|
2022
Q2 | $12K | Sell |
433
-73
| -14% | -$2.47K | ﹤0.01% | 1873 |
|
|
2022
Q1 | $18K | Hold |
506
| – | – | ﹤0.01% | 1844 |
|
|
2021
Q4 | $12K | Hold |
506
| – | – | ﹤0.01% | 2095 |
|
|
2021
Q3 | $12K | Hold |
506
| – | – | ﹤0.01% | 2132 |
|
|
2021
Q2 | $11K | Buy |
506
+50
| +11% | +$1.15K | ﹤0.01% | 2151 |
|
|
2021
Q1 | $9K | Hold |
456
| – | – | ﹤0.01% | 2407 |
|
|
2020
Q4 | $10K | Sell |
456
-425
| -48% | -$7.47K | ﹤0.01% | 2205 |
|
|
2020
Q3 | $11K | Hold |
881
| – | – | ﹤0.01% | 1904 |
|
|
2020
Q2 | $12K | Hold |
881
| – | – | ﹤0.01% | 1830 |
|
|
2020
Q1 | $10K | Hold |
881
| – | – | ﹤0.01% | 1807 |
|
|
2019
Q4 | $22K | Sell |
881
-24
| -3% | -$546 | ﹤0.01% | 1631 |
|
|
2019
Q3 | $21K | Buy |
905
+124
| +16% | +$2.91K | ﹤0.01% | 1565 |
|
|
2019
Q2 | $19K | Hold |
781
| – | – | ﹤0.01% | 1647 |
|
|
2019
Q1 | $21K | Hold |
781
| – | – | ﹤0.01% | 1542 |
|
|
2018
Q4 | $16K | Hold |
781
| – | – | ﹤0.01% | 1584 |
|
|
2018
Q3 | $26K | Sell |
781
-424
| -35% | -$14K | ﹤0.01% | 1456 |
|
|
2018
Q2 | $39K | Hold |
1,205
| – | – | ﹤0.01% | 1154 |
|
|
2018
Q1 | $33K | Sell |
1,205
-76
| -6% | -$2.33K | ﹤0.01% | 1178 |
|
|
2017
Q4 | $40K | Hold |
1,281
| – | – | ﹤0.01% | 1099 |
|
|
2017
Q3 | $46K | Buy |
+1,281
| New | +$45.5K | ﹤0.01% | 982 |
|
Other funds holding BKR
VCM
VPM
Geneos Wealth Management's BKR Position: Q1 2026 in Review
Geneos Wealth Management increased its Baker Hughes (BKR) stake by 12% in Q1 2026, buying an estimated $750K and bringing the position to 119,724 shares worth $7.31M. The position accounts for 0.17% of the portfolio, ranked #145.
Geneos Wealth Management first reported a position in BKR in Q3 2017 and has held it in 35 quarters since. The position peaked at $9.03M in Q1 2025. 1,149 funds tracked by Wall St. Rank hold BKR as of Q1 2026.
- Geneos Wealth Management held 119,724 shares of Baker Hughes worth $7.31M as of Q1 2026.
- Geneos Wealth Management bought 12,968 Baker Hughes shares in Q1 2026, an estimated $750K.
- Baker Hughes made up 0.17% of Geneos Wealth Management's portfolio in Q1 2026, its #145 holding.
- Geneos Wealth Management first reported a position in Baker Hughes in Q3 2017 and has held it in 35 quarters since.
- Geneos Wealth Management's Baker Hughes position peaked at $9.03M in Q1 2025.
- 1,149 funds tracked by Wall St. Rank held Baker Hughes as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.